H. Matsukura et al., Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome, AM J NEPHR, 21(5), 2001, pp. 362-367
Eighty-six patients (59 males and 27 females) diagnosed with steroid-respon
sive nephrotic syndrome during childhood were identified. The patients were
20-40 years of age (mean 27.0 +/- 5.0) with a mean follow-up period of 19.
5 +/- 5.9 years. All patients had been treated with a long-term tapering co
rticosteroid therapy. Thirty patients had also received a course of cycloph
osphamide (2 mg/kg/day for 12 weeks). Sixty-six had achieved sustained remi
ssion off corticosteroids, while 20 were still receiving corticosteroids to
maintain remission. None of the 86 patients had proteinuria or renal insuf
ficiency at the time of the study. Mean final heights in males and females
were similar (-0.51 +/- 1.21 and -0.23 +/- 1.16 standard deviation score).
Mean final height of 20 steroid-dependent patients was significantly less t
han that of 66 in remission off corticosteroids (p < 0.005). Ten cyclophosp
hamide-treated patients got married and 9 had at least 1 healthy child. In
children with steroid-responsive nephrotic syndrome, the need for corticost
eroid therapy to maintain remission may be associated with decreased adult
height. Patients who received a 12-week course of cyclophosphamide are like
ly to be normally fertile as adults. Copyright (C) 2001 S. Karger AG, Basel
.